Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications

MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications

US Patent 12304931 · Granted May 20, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

MENTSH analogs as therapeutics for diabetes, obesity, and their associated disea2023
MENTSH analogs as therapeutics for diabetes, obesity, and their associated disea2023
MENTSH analogs as therapeutics for diabetes, obesity, and their associated disea2021
MENTSH analogs as therapeutics for diabetes, obesity, and their associated disea2021
Mitochondrial-derived peptide MOTS3 regulates metabolism and cell survival2019
Mitochondrial-derived peptide MOTS3 regulates metabolism and cell survival2018
Method of treatment of type-1 diabetes with humanin analogues2014
Small humanin-like peptides2014
Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodeg2012
Method of treatment of type-1 diabetes with a humanin analogue2011